
C. Warren Ivy
Examiner (ID: 14826)
| Most Active Art Unit | 1505 |
| Art Unit(s) | 1509, 1505, 1203 |
| Total Applications | 542 |
| Issued Applications | 426 |
| Pending Applications | 0 |
| Abandoned Applications | 116 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17368432
[patent_doc_number] => 20220023484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Wound Dressings and Applications Thereof
[patent_app_type] => utility
[patent_app_number] => 17/499221
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499221 | Wound dressings and applications thereof | Oct 11, 2021 | Issued |
Array
(
[id] => 20593542
[patent_doc_number] => 12577244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-17
[patent_title] => Heterocyclic compound and harmful arthropod-controlling composition containing same
[patent_app_type] => utility
[patent_app_number] => 18/247369
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 141296
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 2017
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247369
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247369 | Heterocyclic compound and harmful arthropod-controlling composition containing same | Sep 28, 2021 | Issued |
Array
(
[id] => 17561572
[patent_doc_number] => 20220125721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => METHOD OF ENHANCING THE EFFICACY AND STABILITY OF INGREDIENTS IN SUSPENSIONS
[patent_app_type] => utility
[patent_app_number] => 17/489071
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17489071
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/489071 | METHOD OF ENHANCING THE EFFICACY AND STABILITY OF INGREDIENTS IN SUSPENSIONS | Sep 28, 2021 | Abandoned |
Array
(
[id] => 17670123
[patent_doc_number] => 20220183290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => CHEMICALS WHICH ALTER THE PRODUCTION OF METABOLITES IN CULTIVATED PLANTS
[patent_app_type] => utility
[patent_app_number] => 17/480616
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480616 | CHEMICALS WHICH ALTER THE PRODUCTION OF METABOLITES IN CULTIVATED PLANTS | Sep 20, 2021 | Abandoned |
Array
(
[id] => 17774916
[patent_doc_number] => 20220241265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/474816
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14848
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474816
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/474816 | SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES | Sep 13, 2021 | Abandoned |
Array
(
[id] => 17441918
[patent_doc_number] => 20220062423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/471518
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471518
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471518 | EXCIPIENT COMPOUNDS FOR PROTEIN FORMULATIONS | Sep 9, 2021 | Abandoned |
Array
(
[id] => 19150201
[patent_doc_number] => 11975091
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-07
[patent_title] => Composition for enhancing protein strength
[patent_app_type] => utility
[patent_app_number] => 17/472162
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7625
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 351
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17472162
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/472162 | Composition for enhancing protein strength | Sep 9, 2021 | Issued |
Array
(
[id] => 18770722
[patent_doc_number] => 20230365493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => COMPOUNDS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/024720
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21284
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 240
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18024720
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/024720 | COMPOUNDS AND METHODS | Sep 7, 2021 | Pending |
Array
(
[id] => 18751607
[patent_doc_number] => 20230354821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => Gel Capsules Including Silica Gel, and Related Methods
[patent_app_type] => utility
[patent_app_number] => 18/022588
[patent_app_country] => US
[patent_app_date] => 2021-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022588
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/022588 | Gel Capsules Including Silica Gel, and Related Methods | Aug 23, 2021 | Pending |
Array
(
[id] => 19042390
[patent_doc_number] => 11931463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => All-in-one fixed-dose combination for treating
[patent_app_type] => utility
[patent_app_number] => 17/408111
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18613
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17408111
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/408111 | All-in-one fixed-dose combination for treating | Aug 19, 2021 | Issued |
Array
(
[id] => 19667791
[patent_doc_number] => 12180524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-31
[patent_title] => Epigenetic modification of fungi and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/406025
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 34
[patent_no_of_words] => 11454
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406025
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/406025 | Epigenetic modification of fungi and uses thereof | Aug 17, 2021 | Issued |
Array
(
[id] => 17398138
[patent_doc_number] => 20220040228
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => MATERIALS AND METHODS FOR STOPPING RESPIRATORY VIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/444809
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17444809
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/444809 | MATERIALS AND METHODS FOR STOPPING RESPIRATORY VIRUS INFECTIONS | Aug 9, 2021 | Abandoned |
Array
(
[id] => 17748168
[patent_doc_number] => 20220226371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => Synthetic Cellular Membrane Chemical Ionophore Delivery System Comprising Hexa-Aqua Ligand Compositions
[patent_app_type] => utility
[patent_app_number] => 17/390743
[patent_app_country] => US
[patent_app_date] => 2021-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17390743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/390743 | Synthetic Cellular Membrane Chemical Ionophore Delivery System Comprising Hexa-Aqua Ligand Compositions | Jul 29, 2021 | Pending |
Array
(
[id] => 17774908
[patent_doc_number] => 20220241257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Sorafenib particles and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/381705
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/381705 | Sorafenib particles and uses thereof | Jul 20, 2021 | Abandoned |
Array
(
[id] => 18167775
[patent_doc_number] => 20230034383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => METHOD FOR REDUCING SKIN SENSITIZATION OF AN ASENAPINE-CONTAINING PATCH
[patent_app_type] => utility
[patent_app_number] => 17/381294
[patent_app_country] => US
[patent_app_date] => 2021-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/381294 | METHOD FOR REDUCING SKIN SENSITIZATION OF AN ASENAPINE-CONTAINING PATCH | Jul 20, 2021 | Abandoned |
Array
(
[id] => 19120115
[patent_doc_number] => 11964076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Multi-layered polymer film for sustained release of agents
[patent_app_type] => utility
[patent_app_number] => 17/305851
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 14
[patent_no_of_words] => 15975
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305851
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305851 | Multi-layered polymer film for sustained release of agents | Jul 14, 2021 | Issued |
Array
(
[id] => 17952411
[patent_doc_number] => 11478484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Method for preparing a liposomal composition comprising latanoprost, and the pharmacologically active liposomal composition for ophthalmotherapy prepared by this method
[patent_app_type] => utility
[patent_app_number] => 17/375814
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 13913
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17375814
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/375814 | Method for preparing a liposomal composition comprising latanoprost, and the pharmacologically active liposomal composition for ophthalmotherapy prepared by this method | Jul 13, 2021 | Issued |
Array
(
[id] => 19959692
[patent_doc_number] => 12329159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Systems and methods for use of chlorine dioxide in cultivation and post-harvest applications
[patent_app_type] => utility
[patent_app_number] => 17/373544
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12905
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373544
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373544 | Systems and methods for use of chlorine dioxide in cultivation and post-harvest applications | Jul 11, 2021 | Issued |
Array
(
[id] => 18565677
[patent_doc_number] => 20230256004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING MOOD DISORDERS AND CIRCADIAN RHYTHM SLEEP DISORDERS
[patent_app_type] => utility
[patent_app_number] => 18/015011
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015011
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015011 | COMPOSITIONS AND METHODS FOR TREATING MOOD DISORDERS AND CIRCADIAN RHYTHM SLEEP DISORDERS | Jul 7, 2021 | Pending |
Array
(
[id] => 18723489
[patent_doc_number] => 20230337604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => SUPER ABSORBENT POLYMERIC FOAM
[patent_app_type] => utility
[patent_app_number] => 18/005224
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6400
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005224
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005224 | SUPER ABSORBENT POLYMERIC FOAM | Jul 1, 2021 | Pending |